U.S. market Closed. Opens in 17 hours 3 minutes

OBIO | Orchestra BioMed Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
Revenue2.76M3.53M-782.00K5.70M
Cost of Revenue329.50K322.00K199.00K145.00K
Gross Profit2.43M3.21M-981.00K5.56M
Operating Expenses53.94M35.87M20.82M24.31M
Selling, General & Admin20.11M13.92M7.93M10.83M
Research & Development33.82M21.95M12.89M13.48M
Other Operating ExpensesN/AN/AN/AN/A
Operating Income-51.51M-32.66M-21.80M-18.75M
Other Expenses / Income2.39M-951.00K-288.00K-2.93M
Before Tax Income-49.12M-33.61M-23.01M-21.36M
Income Tax Expenses119.11K-222.00K927.00K2.60M
Net Income-49.12M-33.61M-23.01M-21.36M
Interest ExpensesN/AN/A927.00KN/A
Basic Shares Outstanding33.23M14.99M20.45M20.45M
Diluted Shares Outstanding33.23M14.99M20.45M20.45M
EBITDA-51.22M-32.44M-21.62M-15.68M
EBITDA Margin-1,855.76%-918.06%2,764.45%-274.96%
EBIT-49.00M-33.83M-21.16M-18.75M
EBIT Margin-1,775.39%-957.54%2,705.88%-328.81%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙